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1. Introduction
  Several methods are available for the characterization 
of GST fusion proteins, the choice largely depends on 
the experimental situation[1]. For example, SDS-PAGE 
analysis, although frequently used for monitoring results 
during expression and purification, may not be the method 
of choice for routine monitoring of samples from high-
throughput screening[2]. Functional assays based on the 
properties of the protein of interest (as compared to the GST 
tag) are useful, but must be developed for each specific 
protein. Expression and purification of GST fusion proteins 
can be monitored by Western blot analysis to enhance the 
sensitivity of detection system. This requires the availability 
of a specific antibody against the protein of interest and 
monoclonal antibodies are widely used for this purpose. As 
monoclonal antibodies are extremely specific, they can be 
used in association with Western blotting for confirming the 
expression of MSP-2 proteins of different domains and also 
to assess their quality and purity[4]. Hence the production 
of monoclonal antibodies to different regions of MSP-2 has 
been performed in order to assess the quality of expressed 
MSP-2 and also to confirm the immune response against 
different domains of these proteins. Although the technique 
of monoclonal antibody is relatively straightforward[1], the 
successful production of hybrid cell lines producing the 
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monoclonal antibody of desired specificity requires a lot of 
time, effective efforts and probably luck. After isolating a 
positive hybrid line several stages have to be done in order 
to effectively clone a positive hybridoma cell and prepare 
it for long term storage, while ensuring that it has kept its 
potential to produce the antibody of interest. 
2. Materials and methods
  Mice were immunized with a schizont extract, to stimulate 
the immune system to make antibodies against different 
antigens of the late stage parasite, including the production 
of antibodies against different domains of Plasmodium 
falciparum (P. falciparum) MSP-2. B lymphocytes of 
immunized mice were extracted from the spleen and the 
fusion was performed using NS-1 myeloma cells and the 
hybridoma cells were assayed by ELISA either with a 
schizont extract or different domains of MSP-2[5-7] and/or by 
IFAT with whole schizont preparation[6]. Fusion of NS-1 and 
spleen cells was performed. 
2.1. Retrieval and cultivation of myeloma (NS-1) cells
  One Eppendorf tube of NS-1 cell lines (Professor Marcel 
Hommel, LSTM kindly provided the NS-1 cells) were taken 
out from liquid nitrogen and put in a 37 曟 water bath for 
2-3 minutes to thaw the frozen cells quickly. The tube was 
wiped with a 70% ethanol-wet tissue and was taken to a 
laminar flow hood. The NS-1 cell lines were transferred 
to a sterile 15 mL conical tube and washed with 10 mL of 
Iscove’s plus 20% FCS (Foetal Calf Serum) pipetting up and 
down to mix the cells suspension and centrifuge at 1 000 rpm
for 5 minutes to remove the DMSO (dimethylsulfoxide) 
cryoprotectant. 5 mL complete medium (Iscove’s plus 10% 
FCS, 3 mL L-glutamine, 300毺L gentamicine and 1 mL 
8-azaguanine per 100 mL of medium) was added before 
counting the cells using the trypan blue dye exclusion 
method and a haemocytometer. Dilution was made to a 
density of 3伊105 cells/mL and maintained in 25 cm2 tissue 
culture flask (or 15-20 mL in 75 cm2 flask). Cell cultures 
were incubated at 37 曟 incubator with a humid atmosphere 
of 8% CO2 in air and they were checked every 3-4 days 
using an inverted microscope, and if healthy and confluent, 
were diluted to a count of 2伊104 cells per mL in complete 
medium. On the day before fusion the viability of cells was 
determined, as a high viability (3伊105/mL) is required.
2.2. Cell fusion
  All required media including Iscove’s without serum, 
Iscove’s 15% FCS and Iscove’s with OPI and HAT were 
prepared before fusion. The immunized mouse was 
sacrificed  according to the Home Office (UK) guidelines, 
under terminal anesthesia in the animal section of School 
of Tropical Medicine, by a qualified and authorized 
technician. Serum was obtained from the mouse by tail snip 
bleeding[6-8] or by cardiac exsanguinations[9]. Blood samples 
were incubated at room temperature for a few hours; the clot 
removed using sterile tweezers and the serum clarified by 
centrifugation at 4 曟 for 10 minutes. The sera were aliquoted 
in 0.5 mL tubes and stored at -20 曟. A polystyrene white 
board has been prepared and the mouse was pinned out on it 
and sprayed with 70% ethanol. A vertical incision was made 
in the abdomen and the spleen was removed aseptically 
using sterile dissecting instruments while care was taken 
avoiding any injury to intestines or spleen. Three Petri dish 
containing 8 mL of Iscove’s without serum were prepared 
already in order to wash the spleen. The spleen was placed 
in the first Petri dish and transferred to a laminar flow 
hood. The attached tissues and fats were removed under the 
laminar hood and the spleen was washed firstly by swirling 
the Petri dish gently and then by transferring the spleen into 
another Petri dish. Two sterile needles, one bent at an angle 
of 90 曟 to hold the spleen down and the other straight to 
tease the spleen cells out, were used.  The cell suspension 
was then pipetted into a 15 mL sterile conical tube using 
a 10 mL pipette. The suspension was left under the hood 
for few minutes to allow large fragments to settle and then 
the cell suspension was transferred to a new 15 mL sterile 
conical tube centrifuging at 1 000 rpm for 5 minutes at room 
temperature. Supernatant was removed and the cells were 
re-suspended in 2.5 mL of sterile 85% NH4OH (ammonium 
chloride), pipetting up and down to mix the suspension 
and leaving at room temperature for 2 minutes to lyse the 
red blood cells. 10 mL of Iscove’s plus 15% FCS was added 
and the cells were centrifuged at 1 000 rpm for 5 minutes 
in order to wash the NH4OH. The supernatant was removed 
and 10 mL of Iscove’s plus 15% FCS was added and gently 
mixed. An aliquot of spleen cells (e.g. 0.1 mL) was placed 
in an Eppendorf tube and an equal volume of 4% aqueous 
trypan blue was added and cells were counted. It’s usually 
expected that 108 spleen cells to be obtained from the spleen 
of one mouse. An aliquot of NS-1 cells was counted and cells 
were combined at a ratio of 10:1 of spleen cells to NS-1 cells 
in a sterile 50 mL conical tube centrifuging at 1 000 rpm for 
5 minutes. The supernatant was removed and the cells were 
re-suspended in 10 mL of Iscove’s without serum in order 
to remove traces of serum. The cells were centrifuged again 
at 1 000 rpm for 5 minutes at room temperature, removing 
the supernatant and mixing the cells by tapping the base 
of the tube. 0.3 mL of warm PEG (Poly Ethylene Glycan) 
1450 was added over the period of 60 seconds with constant 
mixing. In order to increase the number of hybrids PEG/ 10% 
DMSO solution (Sigma) was used[8]. 15 mL of Iscove’s without 
serum was added slowly over a period of 90 seconds. The 
cells were incubated at room temperature for 10 minutes 
followed by centrifugation at 1 000 rpm for 5 minutes. The 
supernatant was removed and the cells were re-suspended 
in 30 mL of OPI+HAT medium for 108 spleen cells. The cells 
were distributed into a 96-well flat-bottomed plate, using 
a 10 mL pipette and adding one drop per well. The plates 
were labeled and incubated in humidified 8% CO2 incubator 
at 37 曟. The cells were re-fed with one drop of OPI+HAT 
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medium after 24 hours. After 6 days the plates were checked 
for hybrid clones and re-feed with OPI+HAT medium. The 
supernatant of hybridoma positive wells were assayed using 
ELISA and IFAT after day 10th to 14th of incubation. 
 
2.3. Cloning
  The positive hybrids were removed by pipetting the 
contents of wells up and down to re-suspend the cells and 
transfer them into a new plate in 3 different dilutions of 
neat, 1:10 and 1:100.  A few days later a second dilution was 
performed and again ELISA was applied against different 
dilutions. The positive clones were transferred to a small 
tissue culture flask and after developing they were assayed 
against schizont extract and the different MSP-2 domains. 
The positive clones were expanded to large (75 cm2) flask and 
cultured under the same conditions. Checking them using 
both ELISA and IFAT and the positive cells were frozen as 
soon as possible.
2.4. Fusion efficiency
  The accuracy of fusion protocol in producing monoclonal 
antibody was evaluated by calculation of fusion efficiency as 
an indication of produced hybridoma using this procedure. 
In other words the higher fusion efficency, the more chance 
of producing monoclonal antibody to the desired antigen. 
The fusion efficiency, which is the number of hybridoma-
containing wells to the total number of wells, was calculated 
for each fusion separately. It has been demonstrated 
that the dilution of cells during OPI-HAT selection is an 
important factor in the growth of single hybrid so that 
the greater dilution of the cells produces fewer cells with 
multiple clones and a higher percentage of wells with 
single clones[10]. More than 25 percent fusion efficiency was 
obtained when the spleen cells and NS-1 were combined 
at a ratio of approximately 1:1 instead of 1:10 respectively. 
Usually from day 10-14 a scoring sheet was used to record 
the result of each fusion, identifying the hybrids for which 
the detection test should have been done.  
2.5. Synthesis and purification of MSP-2 protein
  MSP-2 recombinant protein was synthesized as previously 
described[5,11-13].  Briefly, the corresponding primers for 
domains 1, 2, 3 and 4 of the 3D7 isolate were PCR-amplified 
for directional cloning into BamHI- NotI-linearised pGEX-
4-T-1. After cloning into TOPO-TA vector, the DNAs 
were ligated into the expression vector ( pGEX 4T-1) and 
transformed into DH5 followed by a mini-preparation of 
plasmid DNA. Transformation of DE3 competent cells was 
performed through culturing the transformant cells on 
LB agar plates. Purification of MSP-2 fusion proteins was 
performed according to the Amersham instruction handbook 
and aliquots of each domain was kept at -20 曟 until it 
was used in further steps. As conserved C and N terminal 
domains of MSP-2 are reportedly not as immunogenic as the 
repeated ones and due to the problematic expression of this 
domain, the analyzed results of domain 1 was not achieved 
at this stage[5].
2.6. Characterization of clones
  In order to characterize each hybrid, several tests were 
performed at different times during each stage of cloning 
and sub-cloning. Only the ELISA positive hybrids against 
schizont extract were tested by IFAT and the positives 
hybrids were cloned. The clones were grown and tested 
against crude schizont extract and MSP-2 different domains 
to find the positive clones. The next step was sub-cloning in 
the tissue culture flasks.
2.7. Enzyme linked immunosorbent assay (ELISA)
ELISA was carried out as described by Voller[6]. ELISA 
plates were coated with 100 毺L per well of the schizont 
extract or with MSP-2 recombinant protein of different 
domains in carbonate coating buffer pH 9.6 and incubated 
at 4 曟 overnight. Unbound antigen was removed by three 
times washing with TST (Tris, sodium chloride and Tween 20) 
washing buffer, after which plates were pre-blocked with 
5 % (w/v) skimmed milk in TST and stored at 4 曟 overnight. 
Monoclonal antibodies were diluted at a ratio of 1:100 with 
blocking buffer, of which 100 毺L was added per well 
comparing to one positive control (100 毺L of hyper immune 
毭-globulin) and one negative control (100 毺L of human 
normal serum) at the same dilution in order to determine the 
reaction of each single serum to different domains of MSP-2. 
A horseradish peroxidase (hrp)-conjugate anti human 
IgG was added at a dilution of 1: 1 000 incubating at room 
temperature for two hours. The fresh ABTS (2, 2’-azino-di-
3-ethylbenzthiaoline sulfonic acid) substrate was added 
to develop the reaction. After developing, the reaction was 
stopped by adding 100 毺L of H2SO4 1M. The OD values were 
read at 405 nm using a Dynatech Microtiter Plate reader after 
60 minutes. Positive samples were defined as those giving a 
specific OD above the normal range for the control European 
sera. The normal range was taken as the Mean 依 Standard 
Deviation (SD) of 20 normal human sera with no history of 
malaria. 
2.8. Preparation of IFAT (Indirect Fluorescent Antibody Test) 
slides
  Infected RBCs with 5%-10% parasitaemia with the majority 
of late stage schizont mostly releasing the merozoites were 
used for IFAT. The culture was centrifuged at 2 000 rpm 
for 5 minutes removing the supernatant. The PRBCs were 
washed twice in PBS. 50 毺L of these washed PRBCs was re-
suspended in one ml of PBS. 25 毺L of this suspension were 
dispensed on 12-spot teflon-coated multi-spot microscope 
slides (Hendley-Essex Multiple Microscopic Slide, UK) and 
left under the laminar hood to dry. Slides were labeled and 
kept at -20 曟 in a plastic slide box until use.
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2.9. Ethical committee
  This study was approved by the ethical committee of 
Liverpool School of Tropical Medicine and as the Keneba 
sera collection was donated by Prof. McGregor to the 
Liverpool School of Tropical Medicine. The source of sera 
used was this collection.
3. Results 
  A total number of 7 fusions including 26 plates (2 496 wells) 
were performed, of which 1 336 hybrids were produced and 
the overall efficiency was about 53%, the fusion efficiency 
was acceptable amongst the first 2 fusions performed (plates 
1-6, 54%). In the next batch of fusion (fusion number three) a 
total number of 315 hybrids were produced hence the fusion 
efficiency was 82%, which is the highest level of efficiency 
amongst all fusions (Table 1) The lowest level of fusion 
efficiency was in fusion number 6 (27% efficiency). 
  From all 7 fusions performed 243 clones were grown in 96 
wells plates as they were detected positive against crude 
schizont extract but only 10 clones were finally detected 
positive against different domains of the MSP-2 recombinant 
protein after sub-cloning in tissues culture flasks before 
freezing. The number of the positive hybrids against schizont 
extract antigens for the four plates of the fusion number 
three was as follows: 15 positive hybrids for the plate 
number one, 17 positive for the plate number two, 21 for the 
plate number three and 13 for the plate number four. From 
these positive hybrids to schizont antigens only two clones 
(C6 and A3) remained positive, hence, they were expanded 
in tissue culture flask after sub-cloning and have been 
frozen down, while their supernatant was kept at -20 曟 for 
analysis. These two positive clones reacted to domain 2 and 
4, after second sub-cloning and cultivation in tissue culture 
flasks. The results of the final selected clones in different 
fusions are shown in Table 1.
  ELISA was performed to detect the positive hybrids against 
crude schizont extract by which 53 out of 310 hybrids, 
produced in fusion 1 and 2, were detected as positive. 
Only 15 out of 179 hybrids produced in fusion number four 
detected positive against schizont extract using ELISA. For 
the fusion number four after sub-cloning to a new plate 
by limiting dilution the wells A6, A11, B5, G9, F1, F2 and 
H4 recorded as positive against both schizont extract and 
MSP-2 domains, hence, they have been grown in small 
tissue culture flasks. After expanding the hybrids into a
75 cm2 tissue culture flask, ELISA was performed using their 
supernatant in order to monitor the reactivity of the positive 
clones to schizont extract and MSP-2 different domains 
before freezing the clones. The ELISA results showed that B5 
and F1 clone were positive for MSP-2 domains 2 and 4.  The 
highest frequency of the ELISA positive hybrids to crude 
schizont extract was found for the supernatant of the hybrids 
produced in fusion number 3 (66 out of 315 hybrids).
  In order to confirm the positivity of the selected clones, 
Western blotting was carried out using different domains of 
the MSP-2 recombinant protein, GST, crude schizont extract 
and RBC. The supernatant of both B5 and F1 hybridoma 
cells were more positive against domain 2 of the MSP-2 
recombinant protein in Western blotting test. In addition, 
the reaction of both the mice immune serum and the mice 
normal serum have been assessed against the P. falciparum 
infected RBC (late stage), GST and the MSP-2 different 
domains (Figures 1-5). The immune serum of both mice 
and human has reacted to the most parts of PRBC (schizont 
extract) and also to MSP-2 different domains while normal 
serum had no reaction to them. Western blotting results 
showed that, different domains of the MSP-2 recombinant 
protein and the MSP-2 of the P. falciparum parasite were 
recognized by some of the positive clones and immune sera.
GST          D3          D4        D2        D2      M
Figure 1. C6 positive hybrid against MSP-2 different domains and 
GST.
                                       
Figure 2. Western blot results for mouse immune serum against 
MSP-2 different domains and RBC infected with P. falciparum. 
From left lanes 1 and 2 are domain 2, lane 3 is domain 3 and lane 4 
is domain 4. Lanes 5 and 6 are infected RBC and the last lane is wide 
range marker. Mice immune serum reacted with different domains 
of MSP-2 and also with all antigens of crude schizont extract as this 
serum was immunized with crude schizont extract.
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Figure 3. Western blot results for mouse normal serum against 
MSP-2 domains and GST.
 Lane 1 is GST, lane 2 is MSP-2 domain 3, lane 3 is domain 2, lane 
4 is domain 4 and lane 5 is marker. There is no reaction of mouse 
normal serum against any antigen indicating that mouse immune 
serum in previous and next figures was effectively immunized to most 
antigens of late stage.
Figure 4. Western blot data for assessment of the immunised mice 
serum to schizont extract and MSP-2 different domains.
 Lane1 and 2 are schizont extract Triton soluble and insoluble, lane 
3 is MSP-2 domain1, lane 4 is MSP-2 domain3, lane 5 is MSP-2 
domain 2, lane 6 is MSP-2 domain 4, lanes 7-9 are schizont extract 
and lane 10 is marker. Mice immune serum reacted with all MSP-2 
domains and Triton soluble and insoluble extracts indicating that mice 
were immunized properly.
Figure 5. Western blot image of monoclonal antibody against Schizont 
extract antigen compared to RBC. 
From left, the Lane 1 and 6 is marker, lanes 2, 3, 7 and 8 are late 
stage P. falciparum A4 isolate Triton soluble and insoluble, lanes 4 
and 9 is RBC and lane 5 and 10 are PRBC. Monoclonal antibody has 
recognized MSP-2 intact molecule at about 50 kDa.
4. Discussion
  The high reactivity of immune serum to schizont extract 
antigens as a control for the monoclonal antibody was 
expected as some researchers have already reported it[11]. 
MSP-2 has been detected by monoclonal antibody C6 at 
approximately 48 kDa on Western blo. Also this monoclonal 
antibody has detected the domains 2 and 4 of MSP-2 
on Western blot strongly. These findings confirmed the 
quality of the MSP-2 recombinant proteins synthesized 
in the current study, which was important for my purpose 
in order to assess the age, related immune responses to 
MSP-2 different domains. The crude schizont extract was 
used to immunize the mice[14,15] and produce monoclonal 
antibody against different domains of MSP-2. Western 
blot was performed using different domains of MSP-2 and 
crude schizont extract in order to identify each monoclonal 
antibody. Once the specific monoclonal antibody was 
recognized, the quality of recombinant proteins were 
analysed in comparison to other evidences. As mice immune 
sera and monoclonal antibody C6 both recognized the full-
length intact MSP-2 protein and also the MSP-2 different 
domains have been recognized by monoclonal antibody 
Table  1
The frequency and efficiency of the different fusions.
Fusions Number of Wells Number of hybrids Fusion efficiency Schizont positive clones MSP-2 positive clones Final selected clones
Fusion 1, 2   576   310 54%   53   1 A6
Fusion 3   384   315 82%   66   2 C6, A3
Fusion 4   384   179 48%   15   2 B5, F1
Fusion 5   384   192 50%   60   1 E6
Fusion 6   384   106 27%   16   2 B5, B4
Fusion 7   384   234 60%   33   2 G5, E5
Total 2496 1336 53% 243 10 -
Overall fusion efficiency was 53% with the higher efficiency for fusion 3. 10 clones had reaction against different domains of MSP-2.
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and by malaria immune sera from Keneba collection, 
these data together with the data of analyses sequencing of 
MSP-2 different domains all confirmed the quality of MSP-2 
recombinant proteins[15,16]. Western blotting test was more 
accurate than ELISA in detection of positive clones against 
different domains of the MSP-2 recombinant protein. A total 
number of 243 out of 1 336 (22%) of the grown hybrids in all 7 
fusions were detected positive against schizont extract using 
ELISA. The results of the IFAT showed less frequency of 
positive hybrids against schizont extract antigens but mostly 
confirmed the ELISA positive hybrids e.g. 36 out of 53 of the 
schizont positive hybrids by ELISA were confirmed positive 
by IFAT. The supernatant of some wells without hybrids 
were tested against schizont extract as negative control in 
order to compare with ELISA positive hybrids and the results 
showed that there was no reaction against schizont extract 
and MSP-2 domains (results not shown). 
  Bringing together all the results of this study it has been 
confirmed that some clones have recognized both schizont 
extract and different domains of the MSP-2 recombinant 
protein and therefore confirming the quality of the 
synthesized recombinant MSP-2 domains.
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